Subcutaneous Drug Delivery Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026 Subcutaneous drug delivery route has emerged as a promising and viable alternative to intravenous administration. The demand for subcutaneous delivery route is attributed to the rapid development of biologics in fastest growing sector of the pharmaceutical industry. Moreover, the subcutaneous route of administration is generally preferred, as it enables selfmedication, improves quality of life, and thus reduce health care costs. Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/2933 Furthermore, convenience and safety for both patients and medical professionals offered by subcutaneous devices are major factors leading to growth of the global subcutaneous drug delivery market. According to World Health Organization, 2014, around 2 million healthcare professionals suffered from infectious diseases as result of needlestick injuries globally. The retractable nature of prefilled syringes help to overcome this problem acting as an ideal device to reduce the occurrence of needlestick injuries. The global subcutaneous drug delivery market size was valued at US$ 7,077.5 million in 2017 and is expected to exhibit a CAGR of 9.5% over the forecast period (2018–2026). Report includes chapters which deeply display the following deliverable about industry : • Subcutaneous Drug Delivery Market Research Objective and Assumption • Subcutaneous Drug Delivery Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Subcutaneous Drug Delivery Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Subcutaneous Drug Delivery Market , By Regions • Subcutaneous Drug Delivery Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Subcutaneous Drug Delivery Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Subcutaneous Drug Delivery Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Subcutaneous Drug Delivery Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Increasing prevalence of arthritis, multiple sclerosis, and diabetes to propel the global subcutaneous drug delivery market growth. Increasing prevalence of multiple sclerosis (MS), rheumatoid arthritis, diabetes, and food allergies is expected to drive growth of the global subcutaneous drug delivery market, as most of the drugs are administered through subcutaneous drug delivery route. According to the study by National Multiple Sclerosis Society, 2017, an estimated 1 million people in the U.S. are living with MS, where around 200 new cases are diagnosed each week in the U.S. According to the Multiple Sclerosis Trust, 2018, an estimated 2,500,000 people in the world have multiple sclerosis. According to the Arthritis Foundation, 2017, around 41 people were diagnosed with Rheumatoid arthritis (RA) out of every 100,000 people in the U.S. The foundation further states that about 1.3 million Americans have RA. According to the Indian population suffering from combined. The foundation suffering from diabetes in 2035. Diabetes Research Foundation, 2016, around 60% of the world’s diabetes lives in Asia, with around one-half in China and India also states that Western Pacific reported over 138.2 million people 2015, the number for which is expected to rise to 201.8 million by Prevention of needlestick injuries to bolster the market growth. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the global subcutaneous drug delivery market. According to the Health Protection Agency (HPA) report, in 2012, injuries among medical and dental professionals while treating patients increased by 131% (100-231) from 2002 to 2011. Moreover, preference for safety injection devices is increasing among healthcare professionals and manufacturers, as these devices decrease chances of needlestick injuries. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Moreover, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/market-insight/subcutaneous-drug-delivery-market-2933 Key Players Major players operating in the global subcutaneous drug delivery market include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Sanofi S.A., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, and Merck & Co., Inc. About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702
Subcutaneous drug delivery route has emerged as a promising and viable alternative to intravenous administration.
© Copyright 2021 Paperzz